Dr. Christophe J. Echeverri (Lead Founder, CEO/CSO): Dr. Echeverri’s training as a molecular cell biologist began with a B.Sc. (Hon.’s, 1990) and an M.Sc. (1992) in Biology, both completed at the University of Ottawa, Canada, studying cytoskeletal processes underlying mammalian neuronal differentiation and cell division. He then completed a Ph.D. in Cell Biology (1998) at the University of Massachusetts (Worcester, MA), focusing on the role of microtubule-based motors in a wide range of cellular processes including cell division. In 1998, he joined the laboratory of Prof. Anthony Hyman at the EMBL (Heidelberg, Germany) as a postdoctoral research scientist, where he co-directed the genomic RNAi screening project with Dr. Pierre Gönczy. In October 1999,  Dr. Echeverri co-founded Cenix with Drs. Gönczy and Hyman.  Dr. Echeverri was recognized in 2003 as one the world's Top 100 Young Innovators by MIT's Technology Review magazine.

Prof. Dr. Pierre Gönczy (Co-founder): After studying biology at the University of Geneva, Pierre Gönczy obtained his Ph.D. in 1995 studying spermatogenesis in the Drosophila system at The Rockefeller University (New York, USA). During his post-doctoral work in the laboratory of Prof. Anthony Hyman at the EMBL (Heidelberg, Germany), he co-directed the genomic RNAi screening project with Dr. Echeverri, before leaving to establish his own research laboratory at the ISREC (Lausanne) as a senior scientist, where he remains today. In 2005 he became Associate Professor in the School of Life Sciences at EPFL. While not participating directly in Cenix operations, Prof. Gönczy has remained a strong scientific collaborator for the company.
 
Prof. Dr. Anthony A. Hyman (Co-founder): With over 70 publications in leading journals including Nature, Science and Cell, Prof. Hyman is a recognised world leader in the study of animal cell division, and particularly on the role of microtubule-based processes therein. He began this work during his Ph.D. in Biology/Zoology at Cambridge University, Kings College (1988), where he completed landmark research on the early stages of embryogenesis in C. elegans. He then turned to mammalian cells and in vitro systems during his post-doctoral work with Dr. Tim Mitchison at the Univ. of California-San Francisco (1988-1993), before expanding to the combined use of multiple experimental systems including yeast, C. elegans, Xenopus, and in vitro assays as a Group Leader at the EMBL (Heidelberg, 1993-1998). Since 1998, he continues this world leading research as a Group Leader and Director at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG, Dresden).  Prof. Hyman was awarded the EMBO Gold Medal in 2003. While not participating directly in Cenix operations, Prof. Hyman has remained a strong scientific collaborator for the company.